<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
84854-003-01
</NDCCode>
<PackageDescription>
64 cm2 in 1 BOTTLE (84854-003-01)
</PackageDescription>
<NDC11Code>
84854-0003-01
</NDC11Code>
<ProductNDC>
84854-003
</ProductNDC>
<ProductTypeName>
HUMAN OTC DRUG
</ProductTypeName>
<ProprietaryName>
Dianas Dream
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Elastic Protein Polypeptide
</NonProprietaryName>
<DosageFormName>
CREAM
</DosageFormName>
<RouteName>
CUTANEOUS
</RouteName>
<StartMarketingDate>
20241024
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
OTC MONOGRAPH DRUG
</MarketingCategoryName>
<ApplicationNumber>
M014
</ApplicationNumber>
<LabelerName>
Guangzhou Kanglixin Medicine Biotechnology Co., Ltd.
</LabelerName>
<SubstanceName>
GLYCERIN
</SubstanceName>
<StrengthNumber>
2
</StrengthNumber>
<StrengthUnit>
g/2cm2
</StrengthUnit>
<Pharm_Classes>
Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]
</Pharm_Classes>
<DEASchedule/>
<Status>
Deprecated
</Status>
<LastUpdate>
2026-01-01
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20251231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
20241024
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage>
Y
</SamplePackage>
</NDC>